+151.8%
MRNA vs FN
-28.3%
+180.2%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 6mo.
| Period | Portfolio | FN | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.2% | +3.1% | -5.4% | -1.7% |
| 7D | +5.5% | -1.7% | +7.2% | +5.2% |
| 30D | +158.7% | -22.0% | +180.7% | +154.1% |
| 3M | +182.1% | -43.0% | +225.1% | +183.5% |
| 6M | +151.8% | -27.7% | +179.6% | +138.9% |
| All | +151.8% | -28.3% | +180.2% | +138.9% |
Cumulative growth
Daily Returns
Daily percentage return beside FN.
Daily Out/Under-Performance
Portfolio return minus FN return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × FN return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 6mo: compounded portfolio wealth divided by compounded FN wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
6mo analysis · Full analysis span regression · 6 months rolling